Fact Source: Financial Supervisory Service DART / 2025-05-22
Disclosure Type: Suspension and Resumption of Trading (Disclosure of Important Matters)
💡 3-Second Summary Following the major announcement of a corporate spin-off, trading for SAMSUNG BIOLOGICS shares and its related futures/options was temporarily suspended for approximately 1 hour and 45 minutes on the morning of May 22 to protect investors, before resuming normally at 09:30 AM.
📊 1. [Key Disclosure Content & Major Figures Summary]
- Target Issue: SAMSUNG BIOLOGICS CO., LTD. Common Stock and its underlying futures/options contracts.
- Type of Trading Suspension: Temporary trading suspension regarding the disclosure of important corporate matters (Decision on Corporate Division).
- Suspension Date & Time: May 22, 2025, at 07:45 AM KST
- Resumption Date & Time: May 22, 2025, at 09:30 AM KST (Total suspension duration: 1 hour and 45 minutes)
- Legal Basis: Article 40 of the KOSPI Market Disclosure Regulations.
- Derivatives Market Impact: In accordance with exchange regulations, listed futures and options tracking SAMSUNG BIOLOGICS were simultaneously suspended and resumed along with the underlying equity.
📈 2. [Expert Insight: What This Disclosure Means for Investors] This temporary trading suspension is a standard “market shock absorption mechanism” enforced by the Korea Exchange (KRX). When an enterprise issues an announcement that dramatically alters its corporate structure—such as an equity spin-off—the exchange halts trading to prevent information asymmetry and grant market participants sufficient time to read and interpret the official filing.
It is critical to note that the suspension began before market open (07:45 AM) and was extended 30 minutes into the regular trading session, resuming at 09:30 AM. The exchange purposefully extended the halt past the 09:00 AM market open to suppress extreme order book distortion, panic selling, or blind buying during the initial minutes of the session.
Investors should understand that this halt was an administrative procedure triggered by a major structural event, not a disciplinary action due to accounting issues or delinquency risks. While the regulatory freeze carries zero operational risk, the release of the halt at 09:30 AM is likely to act as a catalyst for elevated intraday price volatility as institutional and retail order flows converge instantly.
📝 Editor’s Comment (by K-STOCK Editor)
The Korea Exchange immediately pulled the emergency brake the moment SAMSUNG BIOLOGICS dropped its massive spin-off bombshell! By locking up the order book from 07:45 AM until 30 minutes after the regular opening bell, the exchange essentially gave the market a mandatory cooldown period to digest the corporate restructuring numbers.
For the first 30 minutes of the regular session, traders were left watching from the sidelines, creating massive pent-up energy in the order queues. This suspension was not a red flag for internal distress; it was a safety barrier erected before a massive liquidity wave hit. The moment the gates opened at 09:30 AM, the real action began—expect heavy volume and sharp price action as the market begins pricing in the newly structured corporate layout!
📢 Disclaimer and Source Information
Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).
Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
